Features of patients with infertility against the background of metabolic syndrome

Capa

Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Metabolic syndrome negatively affects the quality of life of patients, leads to infertility and, therefore, a decrease in the birth rate. Features of patients with infertility against the background of metabolic syndrome are considered.

Sobre autores

S. Maslov

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Autor responsável pela correspondência
Email: rtchilova@gmail.com
ORCID ID: 0009-0007-1215-1059
Rússia, Moscow

R. Chilova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID ID: 0000-0001-6331-3109
Código SPIN: 4137-4848

Professor, MD

Rússia, Moscow

A. Siordia

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID ID: 0000-0002-8796-6443
Código SPIN: 5610-4780

Candidate of Medical Sciences

Rússia, Moscow

M. Zholobova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID ID: 0000-0003-2842-2910

Professor, MD

Rússia, Moscow

M. Kovalev

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID ID: 0000-0002-0426-587X
Código SPIN: 2539-6420

Professor, MD

Rússia, Moscow

I. Gadaeva

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

Email: rtchilova@gmail.com
ORCID ID: 0000-0003-0144-4984
Código SPIN: 9593-1990

Associate Professor, Candidate of Medical Sciences

Rússia, Moscow

R. Kazakov

Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of Russia

Email: rtchilova@gmail.com
ORCID ID: 0000-0003-0802-4229
Código SPIN: 8751-5090

Candidate of Medical Sciences

Rússia, Moscow

E. Sokova

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University); Scientific Centre for Expert Evaluation of Medicinal Products, Ministry of Health of Russia

Email: rtchilova@gmail.com
ORCID ID: 0000-0002-6389-2099
Código SPIN: 5550-4650

Candidate of Medical Sciences

Rússia, Moscow; Moscow

Bibliografia

  1. Carson S.A., Kallen A.N. Diagnosis and Management of Infertility: A Review. JAMA. 2021; 326 (1): 65–76. doi: 10.1001/jama.2021.4788
  2. Broughton D.E., Moley K.H. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril. 2017; 107 (4): 840–7. doi: 10.1016/j.fertnstert.2017.01.017
  3. Talmor A., Dunphy B. Female obesity and infertility. Best Pract Res Clin Obstet Gynaecol. 2015; 29 (4): 498–506. doi: 10.1016/j.bpobgyn.2014.10.014
  4. Ennab F. Atiomo W. Obesity and female infertility. Best Pract Res Clin Obstet Gynaecol. 2023; 89: 102336. doi: 10.1016/j.bpobgyn.2023.102336
  5. Chen C.-I., Hsu M.-I., Lin S.-H. et al. Adiponectin and leptin in overweight/obese and lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2015; 31 (4): 264–8. doi: 10.3109/09513590.2014.984676
  6. van der Steeg J.W., Steures P., Eijkemans M.J.C. et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008; 23 (2): 324–8. doi: 10.1093/humrep/dem371
  7. Silvestris E., de Pergola G., Rosania R. et al.Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018; 16 (1): 22. doi: 10.1186/s12958-018-0336-z
  8. McCartney C.R., Marshall J.C. Clinical Practice. Polycystic Ovary Syndrome. N Engl J Med. 2016; 375 (1): 54–64. doi: 10.1056/NEJMcp1514916
  9. Gesink Law D.C., Maclehose R.F., Longnecker M.P. Obesity and time to pregnancy. Hum Reprod. 2007; 22 (2): 414–20. doi: 10.1093/humrep/del400
  10. Pascuali N., Scotti L., Di Pietro M. et al. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure. Hum Reprod. 2018; 33 (5): 844–59. doi: 10.1093/humrep/dey045
  11. Vilmann L.S., Thisted E., Baker J.L. et al. Development of obesity and polycystic ovary syndrome in adolescents. Horm Res Paediatr. 2012; 78 (5-6): 269–78. doi: 10.1159/000345310
  12. Barrea L., Muscogiuri G., Pugliese G. et al. Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition. Nutrients. 2021; 13 (11): 3925. doi: 10.3390/nu13113925
  13. Bright K., Dube L., Hayden K.A. et al. Effectiveness of psychological interventions on mental health, quality of life and relationship satisfaction for individuals and/or couples undergoing fertility treatment: a systematic review and meta-analysis protocol. BMJ Open. 2020; 10 (7): e036030. doi: 10.1136/bmjopen-2019-036030
  14. Хабибулина М.М., Елистратов Д.Г. Психокоррекционая терапия пациенток с «метаболически здоровым» ожирением. Врач. 2024; 35 (4): 36–41 [Khabibulina M., Elistratov D. Psycho-correction therapy of patients with «metabolically healthy» obesity. Vrach. 2024; 35 (4): 36–41 (in Russ.)]. doi: 10.29296/25877305-2024-04-07

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).